HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Survival outcome comparative analysis of Liver transplantation and radical resection surgery for Klatskin tumor].

AbstractOBJECTIVE:
To compare the survival results of liver transplantation with radical resection for klatskin tumor based on the published literatures.
METHODS:
We retrieved Medline for articles on treatment of klatskin tumor published from January 1996 to December 2014, and choose the literatures including liver transplantation and radical resection. Review Manager 5. 0 software was used to perform the Meta-analysis of the extracted data.
RESULTS:
After performing meta-analysis of 11 studies including 676 patients, we found comparable patient survival rate between liver transplantation group and radical resection group (1-year RR:1. 00, 95% CI:0. 82 - 1. 23, P = 0. 97; 3-year RR:1. 15, 95% CI:0. 75 - 1. 77, P 0. 51, 5-year RR: 1. 37, 95% CI: 0. 74 - 2. 53, P = 0. 32, respectively). No statistical significance of overall survival rate were shown between this 2 groups whether in short-term or long-time, but the total survival trends show the long-time survival of LT group is better than that of RR group which has the potential longer survival time.
CONCLUSIONS:
Liver transplantation was equivalent to radical resection for klatskin tumor treatment in terms of patient survival, with potential higher long-term patient survival rate and lower recurrence. especially for the patients with unrespectable KT or insufficient liver function, LT is superior for clinical outcome.
AuthorsFurong Liu, Yueming Lin, Xiaoshun He, Cheng Zhang, Yi Ma, Xiaofeng Zhu, Guodong Wang, Anbin Hu
JournalZhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi) Vol. 95 Issue 26 Pg. 2109-13 (Jul 14 2015) ISSN: 0376-2491 [Print] China
PMID26710876 (Publication Type: Comparative Study, Journal Article)
Topics
  • Bile Duct Neoplasms
  • Humans
  • Klatskin Tumor
  • Liver Transplantation
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: